Creative Medical Tech Financials - Benzinga

Creative Medical Technology Holdings Inc

CELZNASDAQ

Trade with Public

Trade with Public

$1.03

0.066.19%

À la clôture: Sep 25, 5:00 PM EST

$1.00

-0.03-2.91%

Après les heures: Sep 25, 7:31 PM EST

Aperçu Actualités Prévisions de résultats ÉvénementsDonnées financièresSentiment Actionnariat Comparer Rapport sur les stocks

Creative Medical Tech Financials

Creative Medical Tech (CELZ) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Creative Medical Tech Q1 EPS $(0.38) Beats $(0.39) Estimate

Creative Medical Tech (NASDAQ:CELZ) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.39) by 2.56 percent. This is a 54.22 percent increase over losses of $(0.83) per share

Benzinga Newsdesk

Mid-Day Market Update: Gold Down 1%; Immix Biopharma Shares Spike Higher

Midway through trading Monday, the Dow traded up 0.18% to 36,402.21 while the NASDAQ rose 0.75% to 15,762.21. The S&P also rose, gaining 0.23% to 4,776.99.

Lisa Levin

Mid-Morning Market Update: Markets Edge Higher; Tesla Q4 Deliveries Top Estimates

Following the market opening Monday, the Dow traded up 0.11% to 36,378.68 while the NASDAQ rose 0.18% to 15,673.75. The S&P also rose, gaining 0.11% to 4,771.56.

Lisa Levin

Mid-Morning Market Update: Markets Open Lower; Big Lots Issues Weak Profit Forecast

Following the market opening Friday, the Dow traded down 0.31% to 34,532.63 while the NASDAQ fell 1.44% to 15,160.41. The S&P also fell, dropping 0.60% to 4,549.65.

Lisa Levin

© 2026 Benzinga | All Rights Reserved